| (Values in U.S. Thousands) | Sep, 2022 | Jun, 2022 | Mar, 2022 | Sep, 2021 | Jun, 2021 |
| Sales | 8 | 49 | 0 | 68 | 13 |
| Sales Growth | -84.09% | unch | -100.00% | +413.45% | -84.74% |
| Net Income | -370 | -680 | -575 | 3,958 | -1,347 |
| Net Income Growth | +45.61% | -18.19% | -114.53% | +393.88% | -49.75% |
Ryah Group Inc (RYAH.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
RYAH Group Inc is a data technology company in plant-based medicine. Its Artificial Intelligence platform aggregates and correlates HIPAA-compliant dosing data from seed to consumption. This helps the company to conduct predictive analyses to help doctors, researchers, and end-users create personalized dosing regimens that can accurately foresee patient outcomes. the company also provide other products which are smart inhaler system & smart patch system.
Fiscal Year End Date: 12/31